Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

GLOBAL MARKETS-Stocks grind higher as recovery hopes stand firm

Published 06/17/2020, 08:15 PM
Updated 06/17/2020, 08:20 PM
© Reuters.
EUR/USD
-
USD/JPY
-
XAU/USD
-
US500
-
DJI
-
JP225
-
SPY
-
DX
-
GC
-
LCO
-
ESM24
-
CL
-
IXIC
-
DE10YT=RR
-
US30YT=X
-
CSI300
-
MIWD00000PUS
-

* European shares add to best gains in nearly a month
* Nikkei eases after rally, S&P 500 futures rise
* Mood restrained by surge in virus cases, China/India spat
* Recovery hopes supported by jump in US retail sales
* Virus treatment drug trial also helps

By Marc Jones
LONDON, June 17 (Reuters) - Europe's shares added to their
best gains in almost a month as safety plays lost their lustre
on Wednesday, with hopes of a rapid economic recovery holding
firm against a resurgence of global coronavirus cases.
Data showed U.S. retail sales bounced back sharply in May,
but new infections have hit record highs in six U.S. states, and
China has cut flights and closed schools to contain a fresh
outbreak in Beijing. The theme of a strong global economic rebound "will need to
be balanced against the 2nd wave COVID risks which are more
difficult to assess, and we would argue investors have assumed
to be perhaps more modest than in reality," said MUFG's head of
research, Derek Halpenny.
Politics also lurked as a worry with India reporting 20 of
its soldiers had been killed in clashes with Chinese troops at a
disputed border site, while North Korea rejected a South Korean
offer to send special envoys and said it would redeploy troops
at the border. That was enough to inject a tinge of caution into trading.
Japan's Nikkei .N225 eased 0.5%, after jumping almost 5%
on Tuesday for its biggest daily gain in three months.
Europe's STOXX 600 trimmed its early gains too .EU , but
all the main indexes were still at least 0.6% higher, and U.S.
S&P 500 futures ESc1 were up 0.5% after spending much of the
Asian session wavering either side of flat. .N
Trial results announced on Tuesday showed dexamethasone,
used to reduce inflammation in other diseases such as arthritis,
reduced death rates by around a third among the most severely
ill COVID-19 patients admitted to hospital. "It is one of the best pieces of news we've had through this
whole crisis," British Health Secretary Matt Hancock said.
MSCI's broadest index of world shares .MIWD00000PUS
crawled 0.2% higher, having climbed 2.2% the previous day to
reclaim a good portion of the ground it lost in a relapse last
week.
Chinese blue chips .CSI300 recovered from an early dip to
finish steady despite Beijing's worst resurgence in COVID-19
cases in four months.
That followed a robust session on Wall Street overnight. The
Dow .DJI ended Tuesday up 2.04%, while the S&P 500 .SPX
gained 1.90% and the Nasdaq .IXIC 1.75%.
Hopes for recovery had been bolstered by the data showing
U.S. retail sales data jumped by a record 17.7% in May,
recovering more than half the losses of the previous two months,
though industrial output still lagged. The Trump administration was also reportedly preparing an
up-to $1 trillion infrastructure package, something that was
initially promised more than three years ago. THE WORST?
"There is little doubt that the global economy bottomed in
April and is poised to post record-high growth rates over May
and June, strongly lifting 3Q GDP above its 2Q trough," wrote
economists at JPMorgan.
"But questions about the extent of lasting damage will have
to wait for a number of months before being resolved."
Federal Reserve Chair Jerome Powell cautioned that output
and employment would remain well short of their pre-pandemic
levels for a long time, so there was a "reasonable probability"
that more policy support would be needed. All the talk of recovery caused headwinds for sovereign
bonds.
Thirty-year Treasury yields US30YT=RR were up 2 basis
points at 1.55%, having risen by the most in a month on Tuesday,
while 10-year German Bunds DE10YT=RR led similar moves across
Europe. GVD/EUR
The focus there was also turning to Thursday's latest
European Central Bank funding round of cheap long-term loans,
which will see banks in effect paid to gobble up three-year
funding.
"The tension between better economic data and rising
COVID-19 cases continues to drive market volatility," said
Antoine Bouvet, senior rates strategist at ING in London.
The dollar bounced modestly from recent three-month lows to
stand at 96.978 against a basket of currencies =USD .
The dollar was up a touch on the Japanese yen at 107.34
JPY= , while the euro stood at $1.1244 EUR= , off its recent
top of $1.1422. /FRX
In commodity markets, gold was stuck at $1,717 XAU= and
well within the $1,670/$1,764 range of the past few weeks.
Oil prices swung in and out of the red amid an increase in
U.S. crude inventories. They had climbed 3% on Tuesday after the
International Energy Agency (IEA) raised its oil demand forecast
for 2020. O/R
Brent crude futures LCOc1 were last at $40.45 a barrel
having slithered between $41.46 and $40.06 a barrel, while U.S.
crude CLc1 dipped 60 cents to $37.70.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Asia stock markets https://tmsnrt.rs/2zpUAr4
Asia-Pacific valuations https://tmsnrt.rs/2Dr2BQA
World stocks and oil vs coronavirus cases https://tmsnrt.rs/2YHK4H8
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.